Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Corneal Transplantation | 12 | 2024 | 386 | 3.620 |
Why?
|
Dry Eye Syndromes | 17 | 2022 | 386 | 3.340 |
Why?
|
Corneal Diseases | 8 | 2024 | 636 | 2.080 |
Why?
|
Cornea | 19 | 2024 | 1524 | 1.470 |
Why?
|
Corneal Dystrophies, Hereditary | 3 | 2022 | 81 | 1.100 |
Why?
|
Keratitis | 4 | 2022 | 268 | 1.020 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2017 | 189 | 1.000 |
Why?
|
Corneal Neovascularization | 3 | 2022 | 188 | 0.960 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2022 | 55 | 0.930 |
Why?
|
Tears | 6 | 2022 | 256 | 0.910 |
Why?
|
Cataract | 3 | 2022 | 834 | 0.880 |
Why?
|
Cataract Extraction | 2 | 2017 | 481 | 0.840 |
Why?
|
Keratoconus | 1 | 2022 | 121 | 0.770 |
Why?
|
Corneal Perforation | 4 | 2022 | 32 | 0.770 |
Why?
|
Epithelium, Corneal | 2 | 2020 | 247 | 0.720 |
Why?
|
Angiogenesis Inhibitors | 3 | 2022 | 2038 | 0.690 |
Why?
|
Corneal Opacity | 1 | 2019 | 60 | 0.680 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3508 | 0.660 |
Why?
|
Graft vs Host Disease | 8 | 2023 | 2957 | 0.630 |
Why?
|
Intravitreal Injections | 1 | 2019 | 344 | 0.620 |
Why?
|
Graft Survival | 6 | 2022 | 3737 | 0.600 |
Why?
|
Optics and Photonics | 1 | 2019 | 321 | 0.600 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 245 | 0.580 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2016 | 675 | 0.570 |
Why?
|
Keratoplasty, Penetrating | 4 | 2022 | 155 | 0.570 |
Why?
|
Th17 Cells | 4 | 2020 | 766 | 0.570 |
Why?
|
Corneal Ulcer | 3 | 2023 | 169 | 0.560 |
Why?
|
Eye | 3 | 2020 | 729 | 0.560 |
Why?
|
Corneal Surgery, Laser | 1 | 2016 | 11 | 0.550 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2016 | 88 | 0.490 |
Why?
|
Intraocular Pressure | 3 | 2017 | 1270 | 0.490 |
Why?
|
E-Selectin | 1 | 2016 | 579 | 0.460 |
Why?
|
alpha-MSH | 2 | 2024 | 68 | 0.460 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 903 | 0.450 |
Why?
|
Chemokine CCL20 | 1 | 2013 | 64 | 0.450 |
Why?
|
Corneal Edema | 2 | 2023 | 52 | 0.450 |
Why?
|
Receptors, CCR6 | 1 | 2013 | 81 | 0.440 |
Why?
|
Myeloid Cells | 1 | 2017 | 810 | 0.410 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.400 |
Why?
|
Keratitis, Herpetic | 2 | 2022 | 81 | 0.390 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 109 | 0.370 |
Why?
|
Conjunctiva | 7 | 2022 | 494 | 0.360 |
Why?
|
Retinal Diseases | 1 | 2016 | 683 | 0.360 |
Why?
|
Conjunctivitis | 2 | 2021 | 158 | 0.360 |
Why?
|
Hyperemia | 2 | 2021 | 225 | 0.360 |
Why?
|
Artificial Organs | 3 | 2016 | 204 | 0.330 |
Why?
|
Mice, Inbred BALB C | 12 | 2023 | 6386 | 0.320 |
Why?
|
Antibodies, Neutralizing | 4 | 2024 | 1978 | 0.310 |
Why?
|
Graft Rejection | 3 | 2016 | 4397 | 0.310 |
Why?
|
Disease Models, Animal | 13 | 2023 | 18029 | 0.290 |
Why?
|
Osmolar Concentration | 2 | 2019 | 683 | 0.290 |
Why?
|
Receptors, CCR7 | 3 | 2016 | 108 | 0.280 |
Why?
|
Visual Acuity | 5 | 2022 | 2530 | 0.280 |
Why?
|
Eye Diseases | 2 | 2023 | 669 | 0.280 |
Why?
|
Retina | 2 | 2016 | 2616 | 0.280 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3772 | 0.280 |
Why?
|
Cell Movement | 3 | 2017 | 5217 | 0.270 |
Why?
|
Lacrimal Apparatus | 2 | 2020 | 225 | 0.270 |
Why?
|
Mice, Inbred C57BL | 16 | 2022 | 21827 | 0.270 |
Why?
|
Chemokine CCL21 | 2 | 2016 | 51 | 0.260 |
Why?
|
Anti-Allergic Agents | 2 | 2018 | 141 | 0.260 |
Why?
|
Melanocortins | 1 | 2024 | 11 | 0.240 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 2 | 2015 | 118 | 0.240 |
Why?
|
Mustard Gas | 1 | 2023 | 16 | 0.230 |
Why?
|
Postoperative Complications | 2 | 2016 | 15295 | 0.230 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2022 | 129 | 0.230 |
Why?
|
Flow Cytometry | 9 | 2017 | 5974 | 0.220 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2023 | 123 | 0.220 |
Why?
|
Burns, Chemical | 1 | 2023 | 159 | 0.210 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2024 | 4386 | 0.210 |
Why?
|
Endothelium, Corneal | 3 | 2022 | 199 | 0.200 |
Why?
|
Animals | 28 | 2024 | 168757 | 0.190 |
Why?
|
Eye Infections, Viral | 1 | 2021 | 57 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor C | 3 | 2017 | 126 | 0.190 |
Why?
|
Blast Injuries | 1 | 2024 | 302 | 0.180 |
Why?
|
Mice | 20 | 2024 | 81183 | 0.180 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3870 | 0.170 |
Why?
|
Th1 Cells | 2 | 2015 | 1057 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10180 | 0.170 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.170 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2020 | 2988 | 0.170 |
Why?
|
Interferon-gamma | 3 | 2024 | 3206 | 0.170 |
Why?
|
Tissue Adhesives | 1 | 2020 | 179 | 0.170 |
Why?
|
Ophthalmic Nerve | 2 | 2015 | 43 | 0.160 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 250 | 0.150 |
Why?
|
Lymphangiogenesis | 2 | 2015 | 172 | 0.140 |
Why?
|
Prostheses and Implants | 2 | 2014 | 1387 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1116 | 0.140 |
Why?
|
Posterior Eye Segment | 1 | 2016 | 14 | 0.140 |
Why?
|
Chemokine CCL19 | 1 | 2016 | 35 | 0.140 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 638 | 0.140 |
Why?
|
Dendritic Cells | 3 | 2016 | 2725 | 0.130 |
Why?
|
Corneal Endothelial Cell Loss | 1 | 2015 | 24 | 0.130 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2014 | 27 | 0.130 |
Why?
|
Military Personnel | 1 | 2024 | 1133 | 0.130 |
Why?
|
Conjunctival Diseases | 1 | 2016 | 122 | 0.130 |
Why?
|
Phacoemulsification | 1 | 2017 | 149 | 0.130 |
Why?
|
Tobramycin | 1 | 2014 | 69 | 0.130 |
Why?
|
Lens Implantation, Intraocular | 1 | 2017 | 192 | 0.130 |
Why?
|
Humans | 34 | 2024 | 744343 | 0.120 |
Why?
|
Methylprednisolone | 1 | 2016 | 387 | 0.120 |
Why?
|
Aqueous Humor | 1 | 2014 | 161 | 0.120 |
Why?
|
Glaucoma | 1 | 2023 | 1159 | 0.120 |
Why?
|
Wound Healing | 2 | 2023 | 2785 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1185 | 0.110 |
Why?
|
P-Selectin | 1 | 2016 | 600 | 0.110 |
Why?
|
Scopolamine | 1 | 2013 | 99 | 0.110 |
Why?
|
Androstadienes | 1 | 2014 | 346 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4149 | 0.110 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2012 | 33 | 0.110 |
Why?
|
Optic Nerve Diseases | 1 | 2016 | 327 | 0.110 |
Why?
|
Fluorophotometry | 3 | 2018 | 40 | 0.110 |
Why?
|
Tacrolimus | 1 | 2016 | 743 | 0.110 |
Why?
|
Cell Proliferation | 3 | 2017 | 10481 | 0.110 |
Why?
|
Lymphoid Tissue | 1 | 2013 | 455 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5442 | 0.100 |
Why?
|
Interleukin-7 | 1 | 2012 | 142 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2016 | 596 | 0.100 |
Why?
|
Nerve Degeneration | 1 | 2016 | 748 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1741 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2014 | 936 | 0.100 |
Why?
|
Ophthalmic Solutions | 3 | 2021 | 317 | 0.100 |
Why?
|
Microscopy, Confocal | 4 | 2023 | 1970 | 0.100 |
Why?
|
Transplantation, Homologous | 5 | 2017 | 4776 | 0.090 |
Why?
|
Fluorescein | 2 | 2022 | 171 | 0.090 |
Why?
|
Lymph Nodes | 3 | 2016 | 3474 | 0.090 |
Why?
|
Time Factors | 5 | 2021 | 40075 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 496 | 0.090 |
Why?
|
RNA | 3 | 2016 | 2749 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2016 | 1904 | 0.080 |
Why?
|
Ligands | 1 | 2016 | 3282 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.080 |
Why?
|
Models, Animal | 1 | 2015 | 2171 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2133 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2023 | 77449 | 0.080 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.080 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1889 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 12072 | 0.080 |
Why?
|
Male | 22 | 2023 | 350118 | 0.070 |
Why?
|
Female | 19 | 2023 | 380194 | 0.070 |
Why?
|
Macrophages | 2 | 2023 | 5655 | 0.070 |
Why?
|
Transplantation, Isogeneic | 2 | 2017 | 257 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2635 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1790 | 0.070 |
Why?
|
Antigen-Presenting Cells | 2 | 2023 | 973 | 0.070 |
Why?
|
Disease Management | 1 | 2016 | 2459 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5524 | 0.060 |
Why?
|
Immune Tolerance | 1 | 2013 | 2258 | 0.060 |
Why?
|
Receptors, Melanocortin | 1 | 2024 | 25 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2023 | 3479 | 0.060 |
Why?
|
Signal Transduction | 3 | 2017 | 23403 | 0.060 |
Why?
|
Mechlorethamine | 1 | 2023 | 136 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1632 | 0.060 |
Why?
|
Prospective Studies | 4 | 2022 | 53288 | 0.060 |
Why?
|
Streptozocin | 1 | 2023 | 196 | 0.060 |
Why?
|
Tissue Preservation | 1 | 2023 | 182 | 0.060 |
Why?
|
Cytoprotection | 1 | 2023 | 210 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4420 | 0.050 |
Why?
|
Middle Aged | 11 | 2022 | 213383 | 0.050 |
Why?
|
Eye Pain | 1 | 2022 | 47 | 0.050 |
Why?
|
Descemet Membrane | 1 | 2022 | 73 | 0.050 |
Why?
|
Axons | 2 | 2023 | 1684 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2017 | 1341 | 0.050 |
Why?
|
Substance P | 1 | 2022 | 335 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2023 | 390 | 0.050 |
Why?
|
Chronic Disease | 3 | 2021 | 9146 | 0.050 |
Why?
|
Cyanoacrylates | 1 | 2020 | 49 | 0.050 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2012 | 2958 | 0.050 |
Why?
|
Optic Nerve | 1 | 2023 | 554 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2023 | 992 | 0.050 |
Why?
|
Interleukin-1beta | 2 | 2016 | 972 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 72290 | 0.040 |
Why?
|
Cytokines | 3 | 2020 | 7322 | 0.040 |
Why?
|
Inflammation | 3 | 2024 | 10638 | 0.040 |
Why?
|
Cell Death | 1 | 2024 | 1706 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2018 | 12026 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9274 | 0.040 |
Why?
|
Aged | 8 | 2023 | 163280 | 0.040 |
Why?
|
Environment | 1 | 2024 | 1124 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2014 | 2110 | 0.040 |
Why?
|
Rabbits | 1 | 2023 | 4894 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.040 |
Why?
|
Gene Expression | 2 | 2022 | 7799 | 0.030 |
Why?
|
Cell Line | 2 | 2023 | 15997 | 0.030 |
Why?
|
Vision Disorders | 1 | 2023 | 1058 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2014 | 11366 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 57776 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2016 | 19229 | 0.030 |
Why?
|
Meibomian Glands | 1 | 2014 | 85 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 310 | 0.030 |
Why?
|
Mice, Inbred C3H | 1 | 2016 | 964 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2014 | 63 | 0.030 |
Why?
|
Miniaturization | 1 | 2014 | 164 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 690 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 546 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2014 | 517 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2596 | 0.030 |
Why?
|
Eye Burns | 1 | 2014 | 103 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1100 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2016 | 844 | 0.030 |
Why?
|
Corneal Stroma | 1 | 2014 | 174 | 0.030 |
Why?
|
Eyelid Diseases | 1 | 2014 | 155 | 0.030 |
Why?
|
Isoantigens | 1 | 2014 | 567 | 0.030 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4560 | 0.030 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 141 | 0.020 |
Why?
|
Cell Count | 1 | 2015 | 1856 | 0.020 |
Why?
|
Adult | 6 | 2021 | 214055 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 13033 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2014 | 986 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1028 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1613 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4933 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9727 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 956 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2699 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2020 | 63114 | 0.020 |
Why?
|
Autoimmunity | 1 | 2014 | 1349 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39050 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2263 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4215 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6489 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5391 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11483 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 85781 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29144 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 12804 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7279 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13284 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25043 | 0.010 |
Why?
|
Concepts
(235)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(28)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_